Advances of perioperative acute kidney injury in elderly patients undergoing non-cardiac surgery.
10.11817/j.issn.1672-7347.2023.220629
- Author:
Zhaohua PANG
1
;
Wangyuan ZOU
2
Author Information
1. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008. 208112394@csu.edu.cn.
2. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008. wangyuanzou@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
acute kidney injury;
elderly;
non-cardiac surgery;
peri-operation;
prevention;
susceptibility;
treatment
- MeSH:
Humans;
Aged;
Acute Kidney Injury/prevention & control*;
Kidney;
Risk Factors;
Prognosis;
Incidence;
Postoperative Complications/prevention & control*
- From:
Journal of Central South University(Medical Sciences)
2023;48(5):760-770
- CountryChina
- Language:English
-
Abstract:
The risk of developing perioperative acute kidney injury (AKI) in elderly patients increases with age. The combined involvement of aging kidneys, coexisting multiple underlying chronic diseases, and increased exposure to potential renal stressors and nephrotoxic drugs or invasive procedures constitute susceptibility factors for AKI in elderly patients. The perioperative AKI in elderly patients undergoing noncardiac surgery has its own specific population characteristics, so it is necessary to further explore the characteristics of AKI in elderly patients in terms of epidemiology, clinical diagnosis, risk factors, and preventive and curative measures to provide meaningful clinical advice to improve prognosis, accelerate recovery, and reduce medical burden in elderly patients. Since AKI has the fastest-growing incidence in older patients and is associated with a worse prognosis, early detection, early diagnosis, and prevention of AKI are important for elderly patients in the perioperative period. Large, multicenter, randomized controlled clinical studies in elderly non-cardiac surgery patients with AKI can be conducted in the future, with the aim of providing the evidence to reduce of the incidence of AKI and to improve the prognosis of patients.
